Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CETRORELIX' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Diedrich, K; Ludwig, M; Felberbaum, RE
      The role of gonadotropin-releasing hormone antagonists in in vitro fertilization

      SEMINARS IN REPRODUCTIVE MEDICINE
    2. Limonta, P; Marelli, MM; Moretti, RM
      LHRH analogues as anticancer agents: pituitary and extrapituitary sites ofaction

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Straub, B; Muller, M; Krause, H; Schrader, M; Goessl, C; Heicappell, R; Miller, K
      Increased incidence of luteinizing hormone-releasing hormone receptor genemessenger RNA expression in hormone-refractory human prostate cancers

      CLINICAL CANCER RESEARCH
    4. De Jong, D; Van Hooren, EG; Macklon, NS; Mannaerts, BMJL; Fauser, BCJM
      Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using aGnRH antagonist (orgalutran/antagon) to prevent a premature LH surge: A case report

      JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
    5. Schally, AV; Gual, C
      Some recollections of early clinical studies on hypothalamic hormones: A tale of a successful international collaboration

      ENDOCRINOLOGIST
    6. Lau, HL; Zhu, XM; Leung, PCK; Chan, LW; Chen, GF; Chan, PSF; Yu, KL; Chan, FL
      Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Arencibia, JM; Schally, AV; Halmos, G; Nagy, A; Kiaris, H
      In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses

      ANTI-CANCER DRUGS
    8. Weiss, JM; Oltmanns, K; Gurke, EM; Polack, S; Eick, F; Felberbaum, R; Diedrich, K; Ortmann, O
      Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    9. Lizio, R; Klenner, T; Sarlikiotis, AW; Romeis, P; Marx, D; Nolte, T; Jahn, W; Borchard, G; Lehr, CM
      Systemic delivery of cetrorelix to rats by a new aerosol delivery system

      PHARMACEUTICAL RESEARCH

    10. Cetrorelix acetate - Cetrotide (R) - Treatment of female infertility - Oncolytic - Treatment of BPH

      DRUGS OF THE FUTURE
    11. Nikolettos, N; Al-Hasani, S; Felberbaum, R; Demirel, LC; Kupker, W; Montzka, P; Xia, YX; Schopper, B; Sturm, R; Diedrich, K
      Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    12. Tieva, A; Stattin, P; Wikstrom, P; Bergh, A; Damber, JE
      Gonadotropin-releasing hormone receptor expression in the human prostate

      PROSTATE
    13. Wikland, M; Bergh, C; Borg, K; Hillensjo, T; Howles, CM; Knutsson, A; Nilsson, L; Wood, M
      A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI

      HUMAN REPRODUCTION
    14. Diedrich, K; Frydman, R; Devroey, P; Felberbaum, R; Schally, AV; Reissmann, T; Engel, J
      Comment on the debate article: Embryo implantation: the Rubicon for GnRH antagonists

      HUMAN REPRODUCTION
    15. Akman, MA; Erden, HF; Tosun, SB; Bayazit, N; Aksoy, E; Bahceci, M
      Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospectiverandomized trial

      HUMAN REPRODUCTION
    16. Ortmann, O; Weiss, JM; Diedrich, K
      Embryo implantation and GnRH antagonists - Ovarian actions of GnRH antagonists

      HUMAN REPRODUCTION
    17. Ragni, G; Vegetti, W; Baroni, E; Colombo, M; Arnoldi, M; Lombroso, G; Crosignani, PG
      Comparison of luteal phase profile in gonadotrophin stimulated cycles withor without a gonadotrophin-releasing hormone antagonist

      HUMAN REPRODUCTION
    18. Jensen, JAG; Carroll, RE; Benya, RV
      The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer

      PEPTIDES
    19. Stricker, HJ
      Luteinizing hormone-releasing hormone antagonists in prostate cancer

      UROLOGY
    20. Smithwick, EB; Young, LG
      Histological effects of androgen deprivation on the adult chimpanzee epididymis

      TISSUE & CELL
    21. Smithwick, EB; Young, LG
      Effects of androgen deprivation on the histology of adult chimpanzee testis

      TISSUE & CELL
    22. Lizio, R; Marx, D; Nolte, T; Lehr, CM; Sarlikiotis, AW; Borchard, G; Jahn, W; Klenner, T
      Development of a new aerosol delivery system for systemic pulmonary delivery in anaesthetized and orotracheal intubated rats

      LABORATORY ANIMALS
    23. Hubner, S; Mittmann, S; Moltrecht, R
      LH-control with an GnRH-antagonist Cetrotide (R) 3 mg in a single dose protocol: Open, prospective non-randomised study in 100 patients treated in superovulation cycles

      GEBURTSHILFE UND FRAUENHEILKUNDE
    24. de Jong, D; Macklon, NS; Eijkemans, MJC; Mannaerts, BMJL; Bennink, HJTC; Fauser, BCJM
      Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

      FERTILITY AND STERILITY
    25. Erb, K; Klipping, C; Duijkers, I; Pechstein, B; Schueler, A; Hermann, R
      Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women

      FERTILITY AND STERILITY
    26. Ludwig, M; Riethmuller-Winzen, H; Felberbaum, RE; Olivennes, F; Albano, C; Devroey, P; Diedrich, K
      Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

      FERTILITY AND STERILITY
    27. Macklon, NS; Fauser, BCJM
      Regulation of follicle development and novel approaches to ovarian stimulation for IVF

      HUMAN REPRODUCTION UPDATE
    28. Olivennes, F; Ayoubi, JM; Fanchin, R; Rongieres-Bertrand, C; Hamamah, S; Bouchard, P; Frydman, R
      GnRH antagonist in single-dose applications

      HUMAN REPRODUCTION UPDATE
    29. Ron-El, R; Raziel, A; Schachter, M; Strassburger, D; Kasterstein, E; Friedler, S
      Induction of ovulation after GnRH antagonists

      HUMAN REPRODUCTION UPDATE
    30. Salha, O; Balen, AH
      New concepts in superovulation strategies for assisted conception treatments

      CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    31. Puri, CP; Gopalkrishnan, K; Iyer, KS
      Constraints in the development of contraceptives for men

      ASIAN JOURNAL OF ANDROLOGY
    32. Ludwig, M; Felberbaum, RE; Devroey, P; Albano, C; Riethmuller-Winzen, H; Schuler, A; Engel, W; Diedrich, K
      Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide (R)) in controlled ovarian stimulation for assisted reproduction

      ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    33. Lizio, R; Klenner, T; Borchard, G; Romeis, P; Sarlikiotis, AW; Reissmann, T; Lehr, CM
      Systemic delivery of the GnRH antagonist cetrorelix by intratracheal instillation in anesthetized rats

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    34. Schwahn, M; Nagaraja, NV; Derendorf, H
      Population pharmacokinetic/pharmacodynamic modeling of cetrorelix, a novelLH-RH antagonist, and testosterone in rats and dogs

      PHARMACEUTICAL RESEARCH
    35. Felberbaum, RF; Ludwig, M; Diedrich, K
      Clinical application of GnRH-antagonists

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    36. Ludwig, M; Strik, D; Felberbaum, R; Al-Hasani, S; Diedrich, K
      No significant leukocytosis under controlled ovarian stimulation using theLHRH antagonist Cetrorelix and recFSH

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    37. Christin-Maitre, S; Olivennes, F; Dubourdieu, S; Chabbert-Buffet, N; Charbonnel, B; Frydman, R; Bouchard, P
      Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation

      CLINICAL ENDOCRINOLOGY
    38. Gago, C; Soler, C; Perez-Sanchez, F; Yeung, CH; Cooper, TG
      Effect of cetrorelix on sperm morphology during migration through the epididymis in the cynomolgus macaque (Macaca fascicularis)

      AMERICAN JOURNAL OF PRIMATOLOGY
    39. Schally, AV; Comaru-Schally, AM; Plonowski, A; Nagy, A; Halmos, G; Rekasi, Z
      Peptide analogs in the therapy of prostate cancer

      PROSTATE
    40. Sun, BD; Halmos, G; Schally, AV; Wang, XF; Martinez, M
      Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

      PROSTATE
    41. Itskovitz-Eldor, J; Kol, S; Mannaerts, B
      Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report

      HUMAN REPRODUCTION
    42. Felberbaum, RE; Albano, C; Ludwig, M; Riethmuller-Winzen, H; Grigat, M; Devroey, P; Diedrich, K
      Ovarian stimulation far assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study

      HUMAN REPRODUCTION
    43. Albano, C; Felberbaum, RE; Smitz, J; Riethmuller-Winzen, H; Engel, J; Diedrich, K; Devroey, P
      Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

      HUMAN REPRODUCTION
    44. Oberye, J; Mannaerts, B; Huisman, J; Timmer, C
      Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran (R)) administration by Medi-Jector (R) compared to conventional needle injections

      HUMAN REPRODUCTION
    45. Akman, MA; Erden, HF; Tosun, SB; Bayazit, N; Aksoy, E; Bahceci, M
      Addition of GnRH antagonist in cycles of poor responders undergoing IVF

      HUMAN REPRODUCTION
    46. Posaci, C; Smitz, J; Camus, M; Osmanagaoglu, K; Devroey, P
      Progesterone for the luteal support of assisted reproductive technologies:clinical options

      HUMAN REPRODUCTION
    47. Ravenna, L; Salvatori, L; Morrone, S; Lubrano, C; Cardillo, MR; Sciarra, F; Frati, L; Di Silverio, F; Petrangeli, E
      Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP

      JOURNAL OF ANDROLOGY
    48. Pechstein, B; Nagaraja, NV; Hermann, R; Romeis, P; Locher, M; Derendorf, H
      Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    49. Halmos, G; Arencibia, JM; Schally, AV; Davis, R; Bostwick, DG
      High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

      JOURNAL OF UROLOGY
    50. Devroey, P
      GnRH antagonists

      FERTILITY AND STERILITY
    51. Bouchard, P; Fauser, BCJM
      Gonadotropin-releasing hormone antagonist: new tools vs. old habits

      FERTILITY AND STERILITY
    52. Erb, K; Pechstein, B; Schueler, A; Engel, J; Hermann, R
      Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men -a first-dose-in-humans study

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    53. Niwa, M; Enomoto, K; Yamashita, K
      Measurement of the novel decapeptide cetrorelix in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    54. Han, YG; Kang, SS; Seong, JY; Geum, D; Suh, YH; Kim, K
      Negative regulation of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression by a gonadotropin-releasing hormoneagonist in the rat hypothalamus

      JOURNAL OF NEUROENDOCRINOLOGY
    55. Schally, AV
      LH-RH analogues: I. Their impact on reproductive medicine

      GYNECOLOGICAL ENDOCRINOLOGY
    56. Rolf, C; Gottschalk, I; Behre, HM; Rauch, C; Thyroff, U; Nieschlag, E
      Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    57. Kol, S; Lightman, A; Hillensjo, T; Devroey, P; Fauser, B; Tarlatzis, B; Mannaerts, B; Itskovitz-Eldor, J
      High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles

      HUMAN REPRODUCTION
    58. Albano, C; Smitz, J; Tournaye, H; Riethmuller-Winzen, H; Van Steirteghem, A; Devroey, P
      Luteal phase and clinical outcome after human menopausal gonadotrophin gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization intracytoplasmic sperm injection cycles

      HUMAN REPRODUCTION
    59. Fauser, BCJM; Devroey, P; Yen, SSC; Gosden, R; Crowley, WF; Baird, DT; Bouchard, P
      Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks

      HUMAN REPRODUCTION
    60. Anderson, RA; Kinniburgh, D; Baird, DT
      Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment

      HUMAN REPRODUCTION
    61. Schally, AV
      Luteinizing hormone-releasing hormone analogs: their impact on the controlof tumorigenesis

      PEPTIDES
    62. Yeung, CH; Weinbauer, GF; Cooper, TG
      Effect of acute androgen withdrawal by GnRH antagonist on epididymal spermmotility and morphology in the cynomolgus monkey

      JOURNAL OF ANDROLOGY
    63. Barbieri, RL; Hornstein, MD
      Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues

      ENDOCRINE REVIEWS
    64. Danila, DC; Schally, AV; Nagy, A; Alexander, JM
      Selective induction of apoptosis by the cytotoxic analog AN-207 in cells expressing recombinant receptor for luteinizing hormone-releasing hormone

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    65. Weiss, JM; Felberbaum, R; Montzka, P; Ludwig, M; Strik, D; Bals-Pratsch, M; Al-Hasani, S; Ortmann, O; Diedrich, C; Diedrich, K
      Concomitant midcyclic GnRH antagonist treatment (Ganirelix) at different dosages

      GEBURTSHILFE UND FRAUENHEILKUNDE
    66. Oberye, JJL; Mannaerts, BMJL; Kleijn, HJ; Timmer, CJ
      Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran*). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

      FERTILITY AND STERILITY
    67. Miyazaki, M; Schally, AV; Nagy, A; Lamharzi, N; Halmos, G; Szepeshazi, K; Armatis, P
      Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    68. OLIVENNES F; RONGIERES C; FANCHIN R; FRYDMAN R
      GNRH ANTAGONISTS USE

      Contraception fertilite sexualite
    69. LAMHARZI N; HALMOS G; ARMATIS P; SCHALLY AV
      EXPRESSION OF MESSENGER-RNA FOR LUTEINIZING-HORMONE-RELEASING HORMONERECEPTORS AND EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN CANCER CELL-LINES

      International journal of oncology
    70. FELBERBAUM RE; LUDWIG M; DIEDRICH K
      ARE WE ON THE VERGE OF A NEW ERA IN ART

      Human reproduction (Oxford. Print)
    71. OLIVENNES F; FRYDMAN R
      FRIENDLY IVF - THE WAY OF THE FUTURE

      Human reproduction
    72. DEJONG D; MACKLON NS; MANNAERTS BMJL; BENNINK HJTC; FAUSER BCJM
      HIGH-DOSE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (GANIRELIX) MAY PREVENT OVARIAN HYPERSTIMULATION SYNDROME CAUSED BY OVARIAN STIMULATIONFOR IN-VITRO FERTILIZATION

      Human reproduction
    73. ITSKOVITZELDOR J; KOL S; MANNAERTS B; BENNINK HC
      FIRST ESTABLISHED PREGNANCY AFTER CONTROLLED OVARIAN HYPERSTIMULATIONWITH RECOMBINANT FOLLICLE-STIMULATING-HORMONE AND THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST GANIRELIX (ORG-37462)

      Human reproduction
    74. MANNAERTS B; DEVROEY P; ABYHOLM T; DIEDRICH K; HILLENSJO T; HEDON B; ITSKOVITZELDOR J; KAHN J; NAETHER O; OLIVENNES F; PAVLOU S; TARLATZIS B; WESTERGAARD L; VANDERHEIJDEN B; COELINGH H
      A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY TO ASSESS THE EFFICACYOF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST GANIRELIX (ORG-37462) TO PREVENT PREMATURE LUTEINIZING-HORMONE SURGES IN WOMEN UNDERGOING OVARIAN STIMULATION WITH RECOMBINANT FOLLICLE-STIMULATING-HORMONE (PUREGON((R)))

      Human reproduction (Oxford. Print)
    75. DIEDRICH K; FELBERBAUM R
      NEW APPROACHES TO OVARIAN STIMULATION

      Human reproduction (Oxford. Print)
    76. Duijkers, IJM; Klipping, C; Willemsen, WNP; Krone, D; Schneider, E; Niebch, G; Hermann, R
      Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

      HUMAN REPRODUCTION
    77. Olivennes, F; Alvarez, S; Bouchard, P; Fanchin, R; Salat-Baroux, J; Frydman, R
      The use of a GnRH antagonist (Cetrorelix (R)) in a single dose protocol inIVF-embryo transfer: a dose finding study of 3 versus 2 mg

      HUMAN REPRODUCTION
    78. SWERDLOFF RS; BAGATELL CJ; WANG C; ANAWALT BD; BERMAN N; STEINER B; BREMNER WJ
      SUPPRESSION OF SPERMATOGENESIS IN MAN-INDUCED BY NAL-GLU GONADOTROPIN-RELEASING-HORMONE ANTAGONIST AND TESTOSTERONE ENANTHATE (TE) IS MAINTAINED BY TE ALONE

      The Journal of clinical endocrinology and metabolism
    79. Ortmann, O; Emons, G; Diedrich, K
      Action mechanisms of gonadotropin-releasing hormone and its analogs

      GYNAKOLOGE
    80. LUDWIG M; FELBERBAUM R; STRIK D; DIEDRICH C; ALHASANI S; DIEDRICH K
      FOLIC-ACID DEFICIENCY ANEMIA RESEMBLING O NSET OF A HELLP-SYNDROME INTWIN PREGNANCY AFTER MAXIMAL STERILITY THERAPY AND INNOVATIVE HORMONAL-STIMULATION

      Geburtshilfe und Frauenheilkunde
    81. ALBANO C; GRIMBIZIS G; SMITZ J; RIETHMULLERWINZEN H; REISSMANN T; VANSTEIRTEGHEM A; DEVROEY P
      THE LUTEAL-PHASE OF NONSUPPLEMENTED CYCLES AFTER OVARIAN SUPEROVULATION WITH HUMAN MENOPAUSAL GONADOTROPIN AND THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETVORELIX

      Fertility and sterility
    82. EMONS G; ORTMANN O; SCHULZ KD; SCHALLY AV
      GROWTH-INHIBITORY ACTIONS OF ANALOGS OF LUTEINIZING-HORMONE-RELEASINGHORMONE ON TUMOR-CELLS

      Trends in endocrinology and metabolism
    83. ARTINI PG; FASCIANI A; CELA V; BATTAGLIA C; DEMICHEROUX AA; DAMBROGIO G; GENAZZANI AR
      FERTILITY DRUGS AND OVARIAN-CANCER

      Gynecological endocrinology
    84. JUNGWIRTH A; GALVAN G; PINSKI J; HALMOS G; SZEPESHAZI K; CAI RZ; GROOT K; SCHALLY AV
      LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX (SB-75) AND BOMBESIN ANTAGONIST RC-3940-II INHIBIT THE GROWTH OF ANDROGEN-INDEPENDENT PC-3 PROSTATE-CANCER IN NUDE-MICE

      The Prostate
    85. GONZALEZBARCENA D; ALVAREZ RB; OCHOA EP; CORNEJO IC; COMARUSCHALLY AM; SCHALLY AV; ENGEL J; REISSMANN T; RIETHMULLERWINZEN H
      TREATMENT OF UTERINE LEIOMYOMAS WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX

      Human reproduction
    86. KAMISCHKE A; BEHRE HM; WEINBAUER GF; NIESCHLAG E
      THE CYNOMOLGUS MONKEY PROSTATE UNDER PHYSIOLOGICAL AND HYPOGONADAL CONDITIONS - AN ULTRASONOGRAPHIC STUDY

      The Journal of urology
    87. BEHRE HM; KLIESCH S; PUHSE G; REISSMANN T; NIESCHLAG E
      HIGH LOADING AND LOW MAINTENANCE DOSES OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST EFFECTIVELY SUPPRESS SERUM LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, AND TESTOSTERONE IN NORMAL MEN

      The Journal of clinical endocrinology and metabolism
    88. VONECKARDSTEIN A; KLIESCH S; NIESCHLAG E; CHIRAZI A; ASSMANN G; BEHRE HM
      SUPPRESSION OF ENDOGENOUS TESTOSTERONE IN YOUNG MEN INCREASES SERUM LEVELS OF HIGH-DENSITY-LIPOPROTEIN SUBCLASS LIPOPROTEIN A-I AND LIPOPROTEIN(A)

      The Journal of clinical endocrinology and metabolism
    89. LUDWIG M; MONTZKA P; FELBERBAUM R; ALHASANI S; DIEDRICH C; DIEDRICH K
      STIMULATION BY CLOMIFEN IN INTRACYTOPLASM IC SPERM INJECTION (ICSI)

      Geburtshilfe und Frauenheilkunde
    90. MIYAZAKI M; NAGY A; SCHALLY AV; LAMHARZI N; HALMOS G; SZEPESHAZI K; GROOT K; ARMATIS P
      GROWTH-INHIBITION OF HUMAN OVARIAN CANCERS BY CYTOTOXIC ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE

      Journal of the National Cancer Institute
    91. UBALDI F; ALBANO C; PEUKERT M; RIETHMULLERWINZEN H; CAMUS M; SMITZ J; VANSTEIRTEGHEM A; DEVROEY P
      SUBTLE PROGESTERONE RISE AFTER THE ADMINISTRATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX IN INTRACYTOPLASMIC SPERM INJECTION CYCLES

      Human reproduction
    92. ALBANO C; SMITZ J; CAMUS M; RIETHMULLERWINZEN H; SIEBERTWEIGEL M; DIEDRICH K; VANSTEIRTEGHEM AC; DEVROEY P
      HORMONAL PROFILE DURING THE FOLLICULAR PHASE IN CYCLES STIMULATED WITH A COMBINATION OF HUMAN MENOPAUSAL GONADOTROPIN AND GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (CETRORELIX)

      Human reproduction
    93. FELBERBAUM R; DIEDRICH K
      CLINICAL USE OF GNRN ANALOGS IN THE TREAT MENT OF INFERTILITY - AGONISTS AND ANTAGONISTS

      Der Gynakologe
    94. REISSMANN T; FELBERBAUM R; DIEDRICH K; ENGEL J; COMARUSCHALLY AM; SCHALLY AV
      DEVELOPMENT AND APPLICATIONS OF LUTEINIZING-HORMONE-RELEASING HORMONEANTAGONISTS IN THE TREATMENT OF INFERTILITY - AN OVERVIEW

      Human reproduction
    95. SCHREIER H; ENGEL J; MCNICOL KJ; DERENDORF H; GROOT K; SCHALLY AV
      SYSTEMIC DELIVERY OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) ANTAGONIST CETRORELIX (SB-75) VIA PULMONARY INSTILLATION IN THE UNANESTHETIZED AWAKE SHEEP

      European journal of pharmaceutical sciences
    96. MULLER A; BUSKER E; ENGEL J; KUTSCHER B; BERND M; SCHALLY AV
      STRUCTURAL INVESTIGATION OF CETRORELIX, A NEW POTENT AND LONG-ACTING LH-RH ANTAGONIST

      International journal of peptide & protein research
    97. LOCHER M; JOHNSTON J; MULLER T; BORBE HO; KUTSCHER B; ENGEL J
      SYNTHESIS OF [U-C-14]ARG LABELED DECAPEPTIDE CETRORELIX, A NOVEL LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST

      Journal of labelled compounds & radiopharmaceuticals
    98. REISSMANN T; DIEDRICH K; COMARUSCHALLY AM; SCHALLY AV
      INTRODUCTION OF LHRH-ANTAGONISTS INTO THE TREATMENT OF GYNECOLOGICAL DISORDERS

      Human reproduction


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 03:01:12